HFA Premium Access

Prevention of HF with special populations: the case of obesity, diabetes, and CKD

Congress Presentation

About the speaker

Doctor Brenda Moura

Military Hospital, Porto (Portugal)
19 presentations
9 followers

3 more presentations in this session

Beneficial effects of SGLT2 inhibitors in patients with heart failure and kidney disease – What and why?

Speaker: Professor J. Tamargo (Madrid, ES)

Thumbnail

Advances in heart failure prevention: development of miRNA therapeutics for cardioprotection

Speaker: Professor P. Ferdinandy (Budapest, HU)

Thumbnail

Pharmacological management of patients with worsening heart failure

Speaker: Doctor D. Tomasoni (Brescia, IT)

Thumbnail

Access the full session

Heart failure - Improving clinical outcomes in special populations

Speakers: Doctor B. Moura, Professor J. Tamargo, Professor P. Ferdinandy, Doctor D. Tomasoni
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb